Anda di halaman 1dari 16

Ketersediaan Obat dan Vaksin COVID-19

23 September 2021

RAPAT DENGAR PENDAPAT KOMISI IX DPR-RI

DIREKTORAT JENDERAL KEFARMASIAN DAN ALAT KESEHATAN


KEMENTERIAN KESEHATAN RI
1. KESIAPAN OBAT DALAM MENDUKUNG TATA
LAKSANA COVID-19
TOPIK 2. KETERSEDIAAN OBAT COVID-19 NASIONAL
3. KETERSEDIAAN DAN RENCANA SUPLAI VAKSIN
COVID-19

2
Monitoring dan Pemilihan/Seleksi*
FORNAS
Evaluasi Manajemen Klinis Tatalaksana

06 01
Standar
NIE atau EUA
Covid-19

Penggunaan : Pelayanan
Kefarmasian 05 Perencanaan
Good Prescribing Practice
Good Pharmacy Practice
02
02 dan Pembiayaan
RKO
FORNAS
Pedoman Teknis Analisis Farmakoekonomi

04 03 Pengadaan
Distribusi E-Purchasing (e-Katalog)
 E-Logistik Cara lain sesuai Perpres
Sesuai dengan  LP-LPO Pengadaan B/J Pemerintah
kebutuhan masing-  Good Distribution Practice
masing daerah
 Good Storage Practice
PBF
 E-Monev Katalog

Penyimpanan Penyaluran Impor


atau Logistik Produksi Bahan Baku Bahan Baku
PERENCANAAN KEBUTUHAN OBAT PENANGANAN COVID-19
Kemkes

Pembahasan perencanaan
Dasar Perencanaan : kebutuhan: Koordinasi
Pedoman VERIFIKASI,
dengan penyusun pedoman, PERMINTAAN PROVINSI
Tatalaksana Covid- praktisi dan unit eselon 1
19 yang disusun 5 Kemenkes yang berkaitan
Organisasi Profesi dengan penanganan
pandemi Covid-19
PERMINTAAAN
FASYANKES, KAB/KOTA
Mekanisme Pendistribusian Obat untuk Penanganan Covid-19
Industri Farmasi/PBF
mendistribusikan obat untuk
penanganan covid-19 ke Kemkes
Kementerian
(sebagai buffer pusat) atau
Kesehatan
Dinkes Prov/Kab/Kota atau RS
sesuai dengan kontrak.

Distribusi obat yang berasal dari


Dinkes Provinsi Kemkes (buffer stok pusat) ke
Dinkes Provinsi dilakukan oleh
Instalasi Farmasi Pusat berdasarkan
permintaan dari Dinkes Provinsi.

Demikian juga dengan distribusi


Keterangan : obat yang berasal dari Dinkes
Dinkes Kab/Kota
Provinsi ke Dinkes Kab/Kota
Alur Pendistribusian dilakukan atas permintaan dari
Dinkes Kab/Kota.
Alur Permintaan
Distribusi obat dari Dinkes
Fasyankes Kab/Kota ke Fasyankes dilakukan
berdasarkan permintaan dari
Fasyankes bila terjadi kekurangan
di Fasyankes.
1. KESIAPAN OBAT DALAM MENDUKUNG TATA
LAKSANA COVID-19
TOPIK 2. KETERSEDIAAN OBAT COVID-19 NASIONAL
3. KETERSEDIAAN DAN RENCANA SUPLAI VAKSIN
COVID-19

6
Stok nasional obat COVID-19 hingga akhir September
Per 20 September 2021

Tambahan Stok
Kebutuhan Kebutuhan September Stok s.d. Lebih stok
No Obat Stok
September saat ini s.d. Sep akhir Sep s.d. akhir Sep
M2 M3 M4 M5
1 Multivitamin 9.576.000 3.511.200 48.096.989 - - - - 48.096.989 44.585.789
2 Favipiravir 24.048.000 8.817.600 85.950.340 - - 3.720.000 - 89.670.340 80.852.740
3 Remdesivir 514.800 188.760 1.018.654 - - 118.334 8.000 1.144.988 956.228
4 Tocilizumab 400mg/20ml 9.000 3.300 5.962 - - - 2.500 8.462 5.162
5 IVIg 5% 50mg 144.000 52.800 112.754 - 1.800 - - 114.554 61.754
6 Oseltamivir 327.600 120.120 11.875.560 - 128.000 128.000 100.000 12.231.560 12.111.440
7 Azythromycin 117.000 42.900 7.893.850 - 323.000 1.330.000 1.347.610 10.894.460 10.851.560
8 Ivermectin 108.000 39.600 4.678.040 - - - - 4.678.040 4.638.440

Produk impor

Terapi tambahan lainnya

*) Tocilizumab tidak dilayani di Apotek


*) Data Apotek bersumber dari Farmaplus
*) Data Rumah Sakit bersumber dari SIRS

Data 20 September 2021 7


Ketersediaan obat COVID-19 di 34 provinsi (1/4)
Oseltamivir Favipiravir tab
No Provinsi Kasus Aktif Stok/ Stok/
Kebutuhan Provinsi RS Apotek Stok Total Kebutuhan Dinkes RS Apotek Stok Total
Kebutuhan Kebutuhan
1 Aceh 4.600 2.093 210 466 5.066 5.742 274% 153.640 332.000 21.918 7.455 361.373 235%
2 Jawa Barat 4.504 2.049 8.530 41.469 315.199 365.198 17820% 150.434 371.300 295.246 202.802 869.348 578%
3 Jawa Tengah 3.885 1.768 3.590 83.828 58.584 146.002 8260% 129.759 71.630 281.554 143.126 496.310 382%
4 Sumatera Utara 3.462 1.575 12 20.471 22.645 43.128 2738% 115.631 785.750 194.770 60.932 1.041.452 901%
5 Jawa Timur 3.191 1.452 31.150 38.794 68.535 138.479 9538% 106.579 455.200 149.846 193.995 799.041 750%
6 Kalimantan Utara 3.078 1.400 16.700 1.337 1.870 19.907 1421% 102.805 221.900 2.712 9.100 233.712 227%
7 DI Yogyakarta 2.953 1.344 4.780 17.145 73.323 95.248 7089% 98.630 712.500 187.789 41.774 942.063 955%
8 DKI Jakarta 2.569 1.169 131.199 46.739 202.518 380.456 32548% 85.805 971.263 154.031 124.345 1.249.639 1456%
9 Sulawesi Selatan 2.223 1.011 600 3.489 11.583 15.672 1549% 74.248 232.810 53.454 96.921 383.185 516%
10 Lampung 2.003 911 2.000 723 7.234 9.957 1093% 66.900 175.000 11.938 18.301 205.239 307%
11 Bali 2.001 910 600 7.107 31.700 39.407 4328% 66.833 307.700 91.267 117.556 516.523 773%
12 Kalimantan Timur 1.952 888 800 200 31.428 32.428 3651% 65.197 23.400 24.932 87.365 135.697 208%
13 Sumatera Barat 1.928 877 - 7.062 70.002 77.064 8785% 64.395 259.700 9.546 28.575 297.821 462%
14 Papua 1.819 828 2.000 5.157 8.269 15.426 1864% 60.755 151.780 24.993 22.245 199.018 328%
15 Kalimantan Tengah 1.709 778 100 15.810 6.291 22.201 2855% 57.081 208.500 60.992 18.806 288.298 505%
16 Bangka Belitung 1.703 775 - 100 260 360 46% 56.880 176.400 9.000 1.640 187.040 329%
17 Riau 1.489 677 - 7.696 8.799 16.495 2435% 49.733 123.100 35.678 15.828 174.606 351%
18 Sulawesi Tengah 1.482 674 - - 6.926 6.926 1027% 49.499 130.200 300 41.845 172.345 348%
19 Nusa Tenggara Timur 1.265 576 580 3.527 11.853 15.960 2773% 42.251 274.000 8.095 20.103 302.198 715%
20 Kalimantan Selatan 1.234 561 2.300 17.721 31.349 51.370 9149% 41.216 28.500 48.172 35.407 112.079 272%
21 Sulawesi Utara 1.211 551 20 1.319 51.518 52.857 9593% 40.447 88.000 18.578 48.064 154.642 382%
22 Banten 1.057 481 50.710 50.966 146.306 247.982 51562% 35.304 316.970 128.343 72.767 518.080 1467%
23 Kepulauan Riau 783 356 - - 23.125 23.125 6491% 26.152 95.900 - 88.328 184.228 704%
24 Jambi 695 316 260 3.873 13.248 17.381 5496% 23.213 51.990 17.519 16.968 86.477 373%
25 Sumatera Selatan 683 311 2.200 10.160 18.918 31.278 10065% 22.812 241.300 41.206 46.402 328.908 1442%
26 Sulawesi Tenggara 553 252 70 3.232 9.259 12.561 4992% 18.470 67.324 4.700 19.356 91.380 495%
27 Sulawesi Barat 406 185 200 - 220 420 227% 13.560 38.000 - 3.130 41.130 303%
28 Nusa Tenggara Barat 351 160 4.000 2.855 13.795 20.650 12930% 11.723 41.000 3.730 47.427 92.157 786%
29 Gorontalo 326 148 970 2.231 1.360 4.561 3075% 10.888 73.300 13.575 32.998 119.873 1101%
30 Kalimantan Barat 306 139 36.600 - 15.710 52.310 37571% 10.220 303.660 - 31.550 335.210 3280%
31 Maluku 229 104 12.200 195 520 12.915 12395% 7.649 49.400 109 1.420 50.929 666%
32 Maluku Utara 121 55 14.750 - 5.931 20.681 37564% 4.041 16.750 - 84.086 100.836 2495%
33 Papua Barat 103 47 - 150 7.490 7.640 16302% 3.440 4.500 - 47.512 52.012 1512%
34 Bengkulu 62 28 600 708 835 2.143 7597% 2.071 133.800 4.561 1.020 139.381 6731%
Total 55.936 25.451 2.003.930 7874% 1.868.262 11.262.230 603%
Buffer Kemenkes 3.770 27.365.840
46661% 4601%
Industri Farmasi & PBF 9.867.860 47.322.270

Data 20 September 2021 8


Ketersediaan obat COVID-19 di 34 provinsi (2/4)
Remdesivir Injeksi vial Azythromycin tab
No Provinsi Kasus Aktif Stok/ Stok/
Kebutuhan Dinkes RS Apotek Stok Total Kebutuhan Dinkes RS Apotek Stok Total
Kebutuhan Kebutuhan
1 Aceh 4.600 3.289 10.430 1.369 - 11.799 359% 748 992 68.539 23.856 93.387 12493%
2 Jawa Barat 4.504 3.220 28.919 16.098 - 45.017 1398% 732 28.200 114.583 357.982 500.765 68420%
3 Jawa Tengah 3.885 2.778 867 16.587 - 17.454 628% 631 1.640 148.908 57.071 207.619 32887%
4 Sumatera Utara 3.462 2.475 3.038 4.488 - 7.526 304% 563 55 48.361 18.158 66.574 11834%
5 Jawa Timur 3.191 2.282 25.508 5.710 - 31.218 1368% 519 23.460 44.402 77.582 145.444 28049%
6 Kalimantan Utara 3.078 2.201 1.376 808 - 2.184 99% 500 11.140 1.932 1.352 14.424 2884%
7 DI Yogyakarta 2.953 2.111 13.639 4.895 - 18.534 878% 480 19.720 25.087 15.491 60.298 12566%
8 DKI Jakarta 2.569 1.837 61.620 13.882 - 75.502 4110% 417 9.793 55.712 110.184 175.689 42085%
9 Sulawesi Selatan 2.223 1.589 4.526 1.975 - 6.501 409% 361 2.070 31.308 17.817 51.195 14172%
10 Lampung 2.003 1.432 4.983 736 - 5.719 399% 325 8.540 5.991 3.387 17.918 5505%
11 Bali 2.001 1.431 3.391 3.682 - 7.073 494% 325 40 22.057 39.790 61.887 19033%
12 Kalimantan Timur 1.952 1.396 19.140 534 - 19.674 1410% 317 1.000 5.671 16.262 22.933 7230%
13 Sumatera Barat 1.928 1.379 1.167 871 - 2.038 148% 313 1.320 6.458 8.785 16.563 5287%
14 Papua 1.819 1.301 4.811 476 - 5.287 407% 296 396.060 17.400 12.925 426.385 144250%
15 Kalimantan Tengah 1.709 1.222 3.193 1.737 - 4.930 403% 278 800 13.044 8.032 21.876 7877%
16 Bangka Belitung 1.703 1.218 2.080 56 - 2.136 175% 277 17.000 1.640 1.275 19.915 7196%
17 Riau 1.489 1.065 478 1.280 - 1.758 165% 242 2.320 24.138 14.989 41.447 17130%
18 Sulawesi Tengah 1.482 1.060 437 - - 437 41% 241 - 17 4.057 4.074 1692%
19 Nusa Tenggara Timur 1.265 904 2.627 403 - 3.030 335% 206 28.940 5.643 8.272 42.855 20848%
20 Kalimantan Selatan 1.234 882 5.524 2.431 - 7.955 902% 201 120 16.099 18.956 35.175 17541%
21 Sulawesi Utara 1.211 866 2.839 2.044 - 4.883 564% 197 120 4.745 15.255 20.120 10224%
22 Banten 1.057 756 13.017 5.508 - 18.525 2451% 172 24.380 440.353 111.448 576.181 335452%
23 Kepulauan Riau 783 560 4.704 - - 4.704 840% 127 10.540 - 23.455 33.995 26718%
24 Jambi 695 497 21.802 1.862 6 23.670 4763% 113 5.115 4.762 6.359 16.236 14376%
25 Sumatera Selatan 683 488 1.974 420 - 2.394 490% 111 3.050 10.355 11.875 25.280 22777%
26 Sulawesi Tenggara 553 395 516 149 - 665 168% 90 1.975 6.177 5.399 13.551 15080%
27 Sulawesi Barat 406 290 356 - - 356 123% 66 5.500 - 331 5.831 8838%
28 Nusa Tenggara Barat 351 251 672 102 - 774 308% 57 5.300 8.488 13.097 26.885 47136%
29 Gorontalo 326 233 356 85 - 441 189% 53 1.730 8.186 1.182 11.098 20950%
30 Kalimantan Barat 306 219 908 - - 908 415% 50 10.940 5 6.215 17.160 34510%
31 Maluku 229 164 2.794 10 - 2.804 1713% 37 7.840 63 518 8.421 22629%
32 Maluku Utara 121 87 700 - - 700 809% 20 6.840 - 12.645 19.485 99097%
33 Papua Barat 103 74 6.051 - - 6.051 8216% 17 35.436 800 3.630 39.866 238184%
34 Bengkulu 62 44 1.791 60 - 1.851 4176% 10 3.330 1.623 1.354 6.307 62600%
Total 55.936 39.994 344.498 861% 9.090 2.846.839 31320%
Buffer Kemenkes 276.182 52.350
2547% 86845%
Industri Farmasi & PBF 397.974 4.994.661

Data 20 September 2021 9


Ketersediaan obat COVID-19 di 34 provinsi (3/4)
Tocilizumab 400mg/20ml Multivitamin
No Provinsi Kasus Aktif Stok/ Stok/
Kebutuhan Dinkes RS Apotek Stok Total Kebutuhan Dinkes RS Apotek Stok Total
Kebutuhan Kebutuhan
1 Aceh 4.600 58 6 - - 6 10% 61.180 5.730 138.820 - 144.550 236%
2 Jawa Barat 4.504 56 18 247 - 265 471% 59.903 266.910 384.288 772.690 1.423.888 2377%
3 Jawa Tengah 3.885 49 43 568 - 611 1258% 51.671 32.560 439.889 346.978 819.427 1586%
4 Sumatera Utara 3.462 43 27 5 - 32 74% 46.045 90.270 129.103 35.839 255.212 554%
5 Jawa Timur 3.191 40 6 239 - 245 614% 42.440 941.660 162.972 574.998 1.679.630 3958%
6 Kalimantan Utara 3.078 38 11 10 - 21 54% 40.937 105.500 4.493 - 109.993 269%
7 DI Yogyakarta 2.953 37 8 75 - 83 225% 39.275 111.180 136.950 260.483 508.613 1295%
8 DKI Jakarta 2.569 32 95 265 - 360 1120% 34.168 229.470 602.685 452.933 1.285.088 3761%
9 Sulawesi Selatan 2.223 28 27 40 - 67 243% 29.566 - 85.921 67.502 153.423 519%
10 Lampung 2.003 25 3 10 - 13 52% 26.640 - 22.176 20.740 42.916 161%
11 Bali 2.001 25 19 15 - 34 138% 26.613 38.490 73.449 87.039 198.978 748%
12 Kalimantan Timur 1.952 24 17 1 - 18 74% 25.962 328.020 36.349 49.512 413.881 1594%
13 Sumatera Barat 1.928 24 20 65 - 85 353% 25.642 108.000 44.359 - 152.359 594%
14 Papua 1.819 23 27 - - 27 119% 24.193 1.067.000 34.752 210.417 1.312.169 5424%
15 Kalimantan Tengah 1.709 21 - - - - 0% 22.730 148.080 39.106 16.282 203.468 895%
16 Bangka Belitung 1.703 21 5 - - 5 23% 22.650 700 2.075 7.775 10.550 47%
17 Riau 1.489 19 24 41 - 65 349% 19.804 264.400 86.115 4.702 355.217 1794%
18 Sulawesi Tengah 1.482 19 2 - - 2 11% 19.711 6.000 2.480 - 8.480 43%
19 Nusa Tenggara Timur 1.265 16 10 60 - 70 444% 16.825 22.830 2.050 161.402 186.282 1107%
20 Kalimantan Selatan 1.234 15 18 80 - 98 635% 16.412 737.670 65.336 17.287 820.293 4998%
21 Sulawesi Utara 1.211 15 - 10 - 10 66% 16.106 10.710 5.202 35.943 51.855 322%
22 Banten 1.057 13 12 142 - 154 1169% 14.058 709.160 535.656 209.910 1.454.726 10348%
23 Kepulauan Riau 783 10 - - - - 0% 10.414 50.800 - 2.620 53.420 513%
24 Jambi 695 9 8 50 - 58 670% 9.244 5.115 13.765 65.244 84.124 910%
25 Sumatera Selatan 683 9 25 3 - 28 328% 9.084 21.500 46.454 66.493 134.447 1480%
26 Sulawesi Tenggara 553 7 - - - - 0% 7.355 68.180 18.142 - 86.322 1174%
27 Sulawesi Barat 406 5 1 - - 1 20% 5.400 5.000 - - 5.000 93%
28 Nusa Tenggara Barat 351 4 7 3 - 10 228% 4.668 24.720 24.996 3.749 53.465 1145%
29 Gorontalo 326 4 - - - - 0% 4.336 619.500 20.126 76 639.702 14754%
30 Kalimantan Barat 306 4 14 - - 14 366% 4.070 60.850 - 6.981 67.831 1667%
31 Maluku 229 3 11 - - 11 398% 3.046 176.240 405 1 176.646 5800%
32 Maluku Utara 121 2 - - - - 0% 1.609 362.130 - - 362.130 22502%
33 Papua Barat 103 1 4 - - 4 311% 1.370 82.060 1.410 7.800 91.270 6663%
34 Bengkulu 62 1 9 - - 9 1135% 825 19.700 1.075 - 20.775 2519%
Total 55.936 699 2.407 344% 743.949 13.366.130 1797%
Buffer Kemenkes 38 254.200
874% 7837%
Industri Farmasi & PBF 3.664 44.682.190

Data 20 September 2021 10


Ketersediaan obat COVID-19 di 34 provinsi (4/4)
IVIg 5% 50 ml Ivermectin
No Provinsi Kasus Aktif Stok/ Stok/
Kebutuhan Dinkes RS Apotek Stok Total Kebutuhan Provinsi RS Apotek Stok Total
Kebutuhan Kebutuhan
1 Aceh 4.600 920 - - - - 0% 690 - - 513 513 74%
2 Jawa Barat 4.504 901 - 319 - 319 35% 676 - - 203.880 203.880 30178%
3 Jawa Tengah 3.885 777 - 936 - 936 120% 583 - - 34.207 34.207 5870%
4 Sumatera Utara 3.462 692 - 809 - 809 117% 519 - - 2.410 2.410 464%
5 Jawa Timur 3.191 638 - 163 - 163 26% 479 - - 34.281 34.281 7162%
6 Kalimantan Utara 3.078 616 - - - - 0% 462 - - 2.380 2.380 515%
7 DI Yogyakarta 2.953 591 - 303 - 303 51% 443 - - 15.326 15.326 3460%
8 DKI Jakarta 2.569 514 - 702 - 702 137% 385 - - 71.449 71.449 18541%
9 Sulawesi Selatan 2.223 445 - - - - 0% 333 - - 16.599 16.599 4978%
10 Lampung 2.003 401 - - - - 0% 300 - - 702 702 234%
11 Bali 2.001 400 - 66 - 66 16% 300 - - 15.175 15.175 5056%
12 Kalimantan Timur 1.952 390 - - - - 0% 293 - - 38.669 38.669 13207%
13 Sumatera Barat 1.928 386 - 156 - 156 40% 289 - - 4.673 4.673 1616%
14 Papua 1.819 364 - - - - 0% 273 - - 1.478 1.478 542%
15 Kalimantan Tengah 1.709 342 - - - - 0% 256 - - 5.942 5.942 2318%
16 Bangka Belitung 1.703 341 - - - - 0% 255 - - 222 222 87%
17 Riau 1.489 298 - 30 - 30 10% 223 - - 2.481 2.481 1111%
18 Sulawesi Tengah 1.482 296 - - - - 0% 222 - - 575 575 259%
19 Nusa Tenggara Timur 1.265 253 - - - - 0% 190 - - 2.335 2.335 1231%
20 Kalimantan Selatan 1.234 247 - - - - 0% 185 - - 3.128 3.128 1690%
21 Sulawesi Utara 1.211 242 - - - - 0% 182 - - 23.132 23.132 12734%
22 Banten 1.057 211 - 123 - 123 58% 159 - - 34.227 34.227 21588%
23 Kepulauan Riau 783 157 - - - - 0% 117 - - 8.525 8.525 7258%
24 Jambi 695 139 - - - - 0% 104 - - 1.696 1.696 1627%
25 Sumatera Selatan 683 137 - 20 - 20 15% 102 - - 8.650 8.650 8443%
26 Sulawesi Tenggara 553 111 - - - - 0% 83 - - 115 115 139%
27 Sulawesi Barat 406 81 - - - - 0% 61 - - 260 260 427%
28 Nusa Tenggara Barat 351 70 - - - - 0% 53 - - 6.782 6.782 12881%
29 Gorontalo 326 65 - - - - 0% 49 - - 640 640 1309%
30 Kalimantan Barat 306 61 - - - - 0% 46 - - 4.008 4.008 8732%
31 Maluku 229 46 - - - - 0% 34 - - 600 600 1747%
32 Maluku Utara 121 24 - - - - 0% 18 - - 5.600 5.600 30854%
33 Papua Barat 103 21 - - - - 0% 15 - - 710 710 4595%
34 Bengkulu 62 12 - - - - 0% 9 - - 690 690 7419%
Total 55.936 11.187 3.627 32% 8.390 552.060 6580%
Buffer Kemenkes - -
1008% 55755%
Industri Farmasi & PBF 109.127 4.125.980

Data 20 September 2021 11


1. KESIAPAN OBAT DALAM MENDUKUNG TATA
LAKSANA COVID-19
2. KETERSEDIAAN DAN MONITORING OBAT COVID-19
TOPIK
NASIONAL
3. KETERSEDIAAN DAN RENCANA SUPLAI VAKSIN
COVID-19

12
RINCIAN RILIS & DISTRIBUSI DOSIS VAKSIN
UNTUK COVID-19

Bulk 153.900.000
2.778.723
15.772.610 20.620.264 5.315.310
Jumlah Rilis 107.332.200 48.760.472 749.502
8.000.160
20.136.284 5.315.310
Terdistribusi 104.368.200 33.814.657 720.766
7.871.318

90% 172.226.535
Siap dikirim 2.946.000 12.548.980 277.630

Stock on hand 18.000 2.396.835 206.310 128.842 28.736

BioFarma CoronaVac AstraZeneca Moderna Pfizer Sinopharm


Distribusi
Siap dikirim BioFarma 2,946,000 Stock on hand BioFarma 18,000
CoronaVac 12,548,980 CoronaVac 2,396,835
Terdistribusi Siap dikirim Stok on hand
Astra Zeneca 277,630 AstraZeneca 206,310
Moderna 128,842
Sinopharm 28,736
Jumlah sudah rilis: 190.777.908
Total 15,772,610 Total 2,778,723

Sumber: Bio Farma // Pfizer Tanggal update data: 21 September 2021


Tabel estimasi ketersediaan vaksin bulan September 2021
Tanggal Datang/ Sinovac Covax/Gavi Total Vaksin
Minggu Astra Zeneca Pfizer Grant Bilateral
Rilis BioVac CoronaVac Multilateral (Dosis)
1/9/21 583,400
2/9/21 1,195,740 500,0005
Minggu ke-1
3/9/21 6,903,000
4/9/21 207,0006 9,389,140
6/9/21 4,761,600 Proses rilis
8/9/21 500,0005
Sudah rilis
9/9/21
Minggu ke-2 2,970,000 358,7001 615,100 639,990 Alokasi disetujui
10/9/21
2,079,0002
11/9/21 2,080,3202 504,2007
Terkirim
12/9/21 2,224,9602 16,733,870
13/9/21 5,238,400 2,223,6802 Keterangan:
14/9/21 2,168,0402 1. AZ – Grant FRA
15/9/21 274,950 2. CoronaVac –
Minggu ke-3 968,3601 1,643,850 Covax
16/9/21
877,5003 3. Pfizer – Covax
17/9/21 2,960,000 5,000,000 1,755,0003 1,877,700 4. AZ – Grant NZ
19/9/21 1,140,7503 26,128,230 5. AZ – Grant AUS
20/9/21 5,000,000 (dose sharing)
21/9/21 5,000,000 200,0008 6. AZ - Grant NED
22/9/21 648,900 1,296,360
7. JnJ – Grant NED
Minggu ke-4 871,6503
23/9/21 8. Sinopharm –
1,236,4801
Grant Red Cross
24/9/21 3,840,000
9. AZ – Grant
26/9/21 122,4009 18,215,790
Singapura
29/9/21 600,000 1,000,00010
30/9/21 6,655,000 2,089,620 1,000,00010
10.CoronaVac –
Minggu ke-5 800,2803 Grant RRT dan
408,0004 Sinovac
219,160 12,772,060

Estimasi Total 23,328,000 25,000,000 19,411,880 4,325,100 7,140,510 4,033,600 83,239,090

Tanggal update data: 21 September 2021


Detail proyeksi ketersediaan vaksin COVID-19 tahun 2021

Distribusi Vaksin

Sinovac AstraZeneca
Covax/Gavi
Novavax Pfizer Grant Bilateral VGR Rilis Bulanan Kumulatif Rilis
Multilateral
Bulk Rilis Vaksin Jadi Thailand RRT

Jan 16.500.000 3.000.000 3.000.000 3.000.000

Q1 Feb 11.000.000 7.871.700 7.871.700 10.871.700

Mar 26.000.000 12.139.700 1.113.600 13.253.300 24.125.000

Apr 12.000.000 8.912.200 3.852.000 500.000 13.264.200 37.389.200

Q2 May 16.000.000 8.843.100 1.444.900 - 10.288.000 47.677.200

Jun 24.000.000 20.051.200 1.817.900 1.000.000 22.869.100 70.546.300

Jul 39.200.000 16.764.300 7.976.560 1 1.041.400 2.911.240 5.500.000 34.193.500 104.739.800

Q3 Aug 9.200.000 19.917.000 25.000.000 4.570.000 2 2.248.600 1.560.780 - 500.000 53.796.380 158.536.180
3
Sep 23.328.000 25.000.000 19.411.880 4.325.100 7.140.510 4.033.600 83.239.090 241.775.270

Oct 4.676.800 14.000.000 22.165.980 3.351.100 14.040.000 4.700.020 4 62.933.900 304.709.170


5
Q4 Nov 18.000.000 22.165.980 3.000.000 15.000.000 14.040.000 4.500.020 76.706.000 381.415.170
5
Dec - 18.000.000 23.481.200 6.033.800 15.000.000 13.218.830 4.650.020 80.383.850 461.799.020

Total 2021 153.900.000 122.504.000 53.000.000 50.000.000 108.000.000 20.000.000 30.000.000 50.000.120 20.794.900 7.500.000 461.799.020 461.799.020

Tentative

Keterangan:
1. Covax: AZ – Grant UK., AZ – Grant NED, Moderna
2. AZ – Grant NZ. AZ – Grant FRA, Pfizer, CoronaVac
3. CoronaVac – Grant RRT, AZ – Grant AUS, AZ – Grant NED, JnJ – Grant NED, Sinopharm – Grant Red Cross, AZ –
Grant Singapura
4. Pfizer – Grant AUS, AZ – Grant AUS, JnJ – Grant NED, Sinopharm – Grant Temasek (Kepri)
5. Pfizer – Grant AUS, AZ – Grant AUS, JnJ – Grant NED 15
Update per tanggal 21 September 2021